William D Waddill's Insider Trades & SAST Disclosures
William D Waddill's most recent trade in Protagonist Therapeutics Inc was a trade of 4,000 Common Stock done at an average price of $54.3 . Disclosure was reported to the exchange on March 17, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern William D Waddill.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Protagonist Therapeutics Inc | William D. Waddill | Director | Sale of securities on an exchange or to another person at price $ 54.25 per share. | 17 Mar 2025 | 4,000 | 13,130 (0%) | 0% | 54.3 | 217,000 | Common Stock |
| Protagonist Therapeutics Inc | William D. Waddill | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 6,584 | 6,584 | - | - | Stock Option (right to buy) | |
| Protagonist Therapeutics Inc | William D. Waddill | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 5,130 | 17,130 (0%) | 0% | 0 | Common Stock | |
| Arrowhead Pharmaceuticals ... | William D. Waddill | Director | Grant, award, or other acquisition of securities at price $ 22.99 per share. | 18 Dec 2024 | 16,733 | 57,111 (0%) | 0% | 23.0 | 384,692 | Common Stock |
| Arrowhead Pharmaceuticals ... | D. William Waddill | Director | Sale of securities on an exchange or to another person at price $ 21.90 per share. | 16 Dec 2024 | 3,748 | 44,125 (0%) | 0% | 21.9 | 82,081 | Common Stock |
| Arrowhead Pharmaceuticals ... | Waddill D. William | Director | Sale of securities on an exchange or to another person at price $ 22.04 per share. | 16 Dec 2024 | 3,747 | 40,378 (0%) | 0% | 22.0 | 82,584 | Common Stock |
| Protagonist Therapeutics Inc | William D. Waddill | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.88 per share. | 10 Sep 2024 | 8,000 | 20,000 (0%) | 0% | 12.9 | 103,040 | Common Stock |
| Protagonist Therapeutics Inc | William D. Waddill | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Sep 2024 | 8,000 | 0 | - | - | Stock Option (right to buy) | |
| Protagonist Therapeutics Inc | William D. Waddill | Director | Sale of securities on an exchange or to another person at price $ 45.00 per share. | 10 Sep 2024 | 8,000 | 12,000 (0%) | 0% | 45 | 360,000 | Common Stock |
| Protagonist Therapeutics Inc | William D. Waddill | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Jul 2024 | 8,000 | 8,000 | - | - | Stock Option (right to buy) | |
| Protagonist Therapeutics Inc | William D. Waddill | Director | Sale of securities on an exchange or to another person at price $ 40.00 per share. | 24 Jul 2024 | 8,000 | 12,000 (0%) | 0% | 40 | 320,000 | Common Stock |
| Protagonist Therapeutics Inc | William D. Waddill | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.88 per share. | 24 Jul 2024 | 8,000 | 20,000 (0%) | 0% | 12.9 | 103,040 | Common Stock |
| Protagonist Therapeutics Inc | William D. Waddill | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jun 2024 | 8,000 | 16,000 | - | - | Stock Option (right to buy) | |
| Protagonist Therapeutics Inc | William D. Waddill | Director | Sale of securities on an exchange or to another person at price $ 35.00 per share. | 07 Jun 2024 | 8,000 | 12,000 (0%) | 0% | 35 | 280,000 | Common Stock |
| Protagonist Therapeutics Inc | William D. Waddill | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.88 per share. | 07 Jun 2024 | 8,000 | 20,000 (0%) | 0% | 12.9 | 103,040 | Common Stock |
| Annexon Inc | William D. Waddill | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 44,000 | 44,000 | - | - | Stock Option (Right to Buy) | |
| Turnstone Biologics Corp | William D. Waddill | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 12,770 | 12,770 | - | - | Stock Option (Right to Buy) | |
| Turnstone Biologics Corp | William D. Waddill | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Apr 2024 | 25,540 | 25,540 | - | - | Stock Option (Right to Buy) | |
| Protagonist Therapeutics Inc | William D. Waddill | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2024 | 12,975 | 0 | - | - | Stock Option (right to buy) | |
| Protagonist Therapeutics Inc | William D. Waddill | Director | Sale of securities on an exchange or to another person at price $ 31.34 per share. | 01 Mar 2024 | 12,975 | 12,000 (0%) | 0% | 31.3 | 406,637 | Common Stock |
| Protagonist Therapeutics Inc | William D. Waddill | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.09 per share. | 01 Mar 2024 | 12,975 | 24,975 (0%) | 0% | 6.1 | 79,018 | Common Stock |
| Arrowhead Pharmaceuticals ... | Waddill William D. | Director | Sale of securities on an exchange or to another person at price $ 37.81 per share. | 11 Jan 2024 | 2,634 | 49,170 (0%) | 0% | 37.8 | 99,592 | Common Stock |
| Arrowhead Pharmaceuticals ... | D. Waddill William | Director | Sale of securities on an exchange or to another person at price $ 38.59 per share. | 11 Jan 2024 | 1,300 | 47,870 (0%) | 0% | 38.6 | 50,167 | Common Stock |
| Protagonist Therapeutics Inc | William D. Waddill | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 25,700 | 25,700 | - | - | Stock Option (right to buy) | |
| Arrowhead Pharmaceuticals ... | William D. Waddill | Director | Grant, award, or other acquisition of securities at price $ 25.41 per share. | 15 Dec 2023 | 14,987 | 51,804 (0%) | 0% | 25.4 | 380,820 | Common Stock |
| Annexon Inc | William D. Waddill | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 24,000 | 24,000 | - | - | Stock Option (Right to Buy) | |
| Protagonist Therapeutics Inc | William D. Waddill | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jan 2023 | 30,000 | 30,000 | - | - | Stock Option (right to buy) | |
| Arrowhead Pharmaceuticals ... | William D. Waddill | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jan 2023 | 7,867 | 36,817 (0%) | 0% | 0 | Common Stock | |
| Arrowhead Pharmaceuticals ... | William D. Waddill | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jan 2023 | 4,593 | 4,593 | - | - | Common Stock | |
| Arrowhead Pharmaceuticals ... | William D. Waddill | Director | Sale of securities on an exchange or to another person at price $ 30.00 per share. | 09 Jan 2023 | 3,200 | 28,950 (0%) | 0% | 30 | 96,000 | Common Stock |
| Annexon Inc | William D. Waddill | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 24,000 | 24,000 | - | - | Stock Option (Right to Buy) | |
| Protagonist Therapeutics Inc | William D. Waddill | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2022 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Protagonist Therapeutics Inc | William D. Waddill | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.59 per share. | 03 May 2022 | 12,000 | 12,000 (0%) | 0% | 8.6 | 103,080 | Common Stock |
| Protagonist Therapeutics Inc | William D. Waddill | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 May 2022 | 12,000 | 0 | - | - | Stock Option (right to buy) | |
| Arrowhead Pharmaceuticals ... | William D. Waddill | Director | Sale of securities on an exchange or to another person at price $ 65.01 per share. | 03 Jan 2022 | 2,128 | 26,022 (0%) | 0% | 65.0 | 138,341 | Common Stock |
| Arrowhead Pharmaceuticals ... | William D. Waddill | Director | Sale of securities on an exchange or to another person at price $ 64.23 per share. | 03 Jan 2022 | 2,100 | 28,150 (0%) | 0% | 64.2 | 134,883 | Common Stock |
| Arrowhead Pharmaceuticals ... | William D. Waddill | Director | Sale of securities on an exchange or to another person at price $ 66.25 per share. | 03 Jan 2022 | 272 | 25,750 (0%) | 0% | 66.3 | 18,020 | Common Stock |
| Annexon Inc | William D. Waddill | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Aug 2021 | 20,000 | 20,000 | - | - | Stock Option (Right to Buy) | |
| Protagonist Therapeutics Inc | William D. Waddill | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2021 | 18,000 | 18,000 | - | - | Stock Option (right to buy) | |
| Arrowhead Pharmaceuticals ... | William D. Waddill | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2021 | 9,000 | 34,000 (0%) | 0% | 0 | Common Stock | |
| Arrowhead Pharmaceuticals ... | William D. Waddill | Director | Sale of securities on an exchange or to another person at price $ 76.08 per share. | 01 Jan 2021 | 3,750 | 30,250 (0%) | 0% | 76.1 | 285,300 | Common Stock |
| Arrowhead Pharmaceuticals ... | William D. Waddill | Director | Sale of securities on an exchange or to another person at price $ 73.10 per share. | 10 Dec 2020 | 1,800 | 25,000 (0%) | 0% | 73.1 | 131,580 | Common Stock |
| Arrowhead Pharmaceuticals ... | William D. Waddill | Director | Sale of securities on an exchange or to another person at price $ 68.50 per share. | 10 Dec 2020 | 1,200 | 26,800 (0%) | 0% | 68.5 | 82,200 | Common Stock |
| Protagonist Therapeutics Inc | William D. Waddill | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2020 | 15,000 | 15,000 | - | - | Stock Option (right to buy) | |
| Arrowhead Pharmaceuticals ... | William D. Waddill | Director | Sale of securities on an exchange or to another person at price $ 36.54 per share. | 11 May 2020 | 26,000 | 28,000 (0%) | 0% | 36.5 | 950,040 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges